Vor Biopharma (VOR) earnings, Oct 30, 2026: EPS +99%, stock −5.9%
In brief
Vor Biopharma reported on Oct 30, 2026. Earnings per share changed +99% year over year, 34.7% below the estimate; revenue 0%. The stock opened with a −4.4% gap and closed the day −5.9% (Oct 30, 2026). The stock is now 28.2% below its 52-week high, −10.8% over 12 months. Next report: Mar 25, 2027.
EPS vs estimate−34.7%
EPS, YoY+99%
Revenue, YoY0%
Gap · day−4.4% · −5.9%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Apr 28, 2026 | −1.2% | −2.4% |
| Jul 28, 2026 | +1.2% | −2.2% |
| Aug 11, 2026 | −1.2% | +0.9% |
| Aug 12, 2026 | −1.5% | +4.3% |
| Oct 30, 2026 | −4.4% | −5.9% |
Next-quarter estimates, ratings and the VOR chart are in the terminal.
Open the terminalFAQ
When is Vor Biopharma's next earnings report?
Mar 25, 2027. The date comes from daily data and is corrected if the company moves it.
How did Vor Biopharma stock react to the report?
Opening gap −4.4%, day's result −5.9%.
Did Vor Biopharma's earnings grow?
Earnings per share rose 99% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.